These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 7872342

  • 1. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
    Kohno M, Horio T, Yokokawa K, Yasunari K, Ikeda M, Minami M, Kurihara N, Takeda T.
    Am J Med; 1995 Mar; 98(3):257-65. PubMed ID: 7872342
    [Abstract] [Full Text] [Related]

  • 2. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Hanehira T, Yoshikawa J.
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [Abstract] [Full Text] [Related]

  • 3. Natriuretic peptides as markers of preclinical cardiac disease in obesity.
    Grandi AM, Laurita E, Selva E, Piantanida E, Imperiale D, Giovanella L, Guasti L, Venco A.
    Eur J Clin Invest; 2004 May; 34(5):342-8. PubMed ID: 15147331
    [Abstract] [Full Text] [Related]

  • 4. New insights into the mechanism of the elevation of plasma brain natriuretic polypeptide levels in patients with left ventricular hypertrophy.
    Murakami Y, Shimada T, Inoue S, Shimizu H, Ohta Y, Katoh H, Nakamura K, Ishibashi Y.
    Can J Cardiol; 2002 Dec; 18(12):1294-300. PubMed ID: 12518181
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril.
    Díez J, Laviades C.
    J Hypertens Suppl; 1994 Jul; 12(4):S31-6. PubMed ID: 7965272
    [Abstract] [Full Text] [Related]

  • 6. B-type natriuretic peptide and left ventricular hypertrophy in hypertensive patients.
    Almeida P, Azevedo A, Rodrigues R, Dias P, Friões F, Vazquez B, Abreu-Lima C, Bettencourt P, Barros H.
    Rev Port Cardiol; 2003 Mar; 22(3):327-36. PubMed ID: 12847875
    [Abstract] [Full Text] [Related]

  • 7. Natriuretic peptides in patients with aortic stenosis.
    Qi W, Mathisen P, Kjekshus J, Simonsen S, Bjørnerheim R, Endresen K, Hall C.
    Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
    [Abstract] [Full Text] [Related]

  • 8. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S, Manhenke C, Squire IB, Ng L, Anand I, Dickstein K.
    J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H, Kanno Y, Kaneko K, Kaneko M, Kotaki S, Mimura T, Takane H.
    Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V, Devereux RB.
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [Abstract] [Full Text] [Related]

  • 11. Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass.
    Rubattu S, Sciarretta S, Ciavarella GM, Venturelli V, De Paolis P, Tocci G, De Biase L, Ferrucci A, Volpe M.
    J Hypertens; 2007 Apr; 25(4):833-9. PubMed ID: 17351376
    [Abstract] [Full Text] [Related]

  • 12. The concentration of atrial and brain natriuretic peptide in patients with idiopathic hypertension.
    Irzmanski R, Barylski M, Banach M, Piechota M, Kowalski J, Cierniewski C, Pawlicki L.
    Med Sci Monit; 2007 Oct; 13(10):CR449-56. PubMed ID: 17901852
    [Abstract] [Full Text] [Related]

  • 13. Effect of angiotensin-converting enzyme inhibitor on left ventricular parameters and circulating brain natriuretic peptide in elderly hypertensives with left venticular hypertrophy.
    Kohno M, Minami M, Kano H, Yasunari K, Maeda K, Hanehira T, Yoshikawa J.
    Metabolism; 2000 Oct; 49(10):1356-60. PubMed ID: 11079829
    [Abstract] [Full Text] [Related]

  • 14. Atrial natriuretic peptide and brain natriuretic peptide release in human essential hypertension.
    Soualmia H, Ayadi I, Omar S, Feki M, Drissa H, Mebazaa A, Kaabachi N.
    Clin Lab; 2009 Oct; 55(3-4):120-7. PubMed ID: 19462934
    [Abstract] [Full Text] [Related]

  • 15. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA, Vyssoulis GP, Karpanou EA, Marinakis AG, Barbetseas JD, Zervoudaki AI, Cokkinos DV, Stefanadis CI.
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [Abstract] [Full Text] [Related]

  • 16. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.
    Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, Kangawa K, Matsuo H, Omae T, Matsuoka H.
    Hypertension; 1996 Jul; 28(1):22-30. PubMed ID: 8675258
    [Abstract] [Full Text] [Related]

  • 17. [Plasma levels of atrial and brain natriuretic peptide and left ventricular geometry in patients with essential hypertension].
    Kosmala W, Spring A.
    Pol Merkur Lekarski; 2003 Mar; 14(81):216-9. PubMed ID: 12914098
    [Abstract] [Full Text] [Related]

  • 18. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
    Brilla CG, Rupp H, Maisch B.
    Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
    [Abstract] [Full Text] [Related]

  • 19. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
    Ovchinnikov AG, Serbul VM, Ageev FT.
    Ter Arkh; 2009 Dec; 81(5):64-71. PubMed ID: 19537590
    [Abstract] [Full Text] [Related]

  • 20. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C, Maria Sironi A, Favilli B, Poletti R, Prontera C, Ripoli A, Lombardi M, Emdin M.
    Int J Cardiol; 2005 Sep 15; 104(1):39-45. PubMed ID: 16137508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.